Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ASD141

Clinical trial NCT06235437 · RECRUITING

Trial details

NCT number: NCT06235437
Sponsor: Ascendo Biotechnology Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Solid Tumor

Start date: 2024-08-29
Primary completion: 2026-12-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.